1,407
Views
38
CrossRef citations to date
0
Altmetric
Review

Novel treatment options in depression and psychosis

&
Pages 741-747 | Published online: 13 Mar 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kunitoshi Kamijima, Moriyoshi Yasuda, Kayo Yamamura & Yasuhiko Fukuta. (2018) Real-world effectiveness and safety of aripiprazole augmentation therapy in patients with major depressive disorder. Current Medical Research and Opinion 34:12, pages 2105-2112.
Read now

Articles from other publishers (37)

Eva Češková. (2023) Latest advances in psychopharmacotherapy: what a pharmacist should know. Farmacie pro praxi 19:1, pages 15-18.
Crossref
Adam Montgomery, Marianna Rogowska & Luiz Dratcu. (2023) Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?. Clinical Psychopharmacology and Neuroscience 21:1, pages 202-206.
Crossref
Gudrun Hefner, Jan Wolff, Sermin Toto, Pamela Reißner & Ansgar Klimke. (2022) Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry. Journal of Neural Transmission 129:11, pages 1353-1365.
Crossref
Jolanta Orzelska-Górka, Joanna Mikulska, Anna Wiszniewska & Grażyna Biała. (2022) New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression. International Journal of Molecular Sciences 23:18, pages 10624.
Crossref
Roger W. Sommi, Bhaskar Rege, Angela Wehr, Sejal Faldu, Yangchun Du & Peter J. Weiden. (2020) Aripiprazole Lauroxil Dosing Regimens: Understanding Dosage Strengths and Injection Intervals. CNS Spectrums 27:3, pages 262-267.
Crossref
Minze Zhu, Andrew K. Whittaker, Felicity Y. Han & Maree T. Smith. (2022) Journey to the Market: The Evolution of Biodegradable Drug Delivery Systems. Applied Sciences 12:2, pages 935.
Crossref
Shabnoor Iqbal, Muhammad Ajmal Shah, Azhar Rasul, Shahid Shah, Ghulam Mujtaba Shah, Muhammad Irfan, Uzma Saleem, Ifat Alsharif, Reem Hasaballah Alhasani, Norah A. Althobaiti, Shafiq Ur Rahman & Abdul Haleem Khan. 2022. The Role of Phytonutrients in Metabolic Disorders. The Role of Phytonutrients in Metabolic Disorders 313 358 .
Carlo Romano Settanni, Gianluca Ianiro, Stefano Bibbò, Giovanni Cammarota & Antonio Gasbarrini. (2021) Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation. Progress in Neuro-Psychopharmacology and Biological Psychiatry 109, pages 110258.
Crossref
Kunal Maini, Janice W. Hollier, Haley Gould, Victoria Bollich, John LaForge, Elyse M. Cornett, Amber N. Edinoff, Adam M. Kaye & Alan D. Kaye. (2021) Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia. Health Psychology Research 9:1.
Crossref
Marsal Sanches, Joao Quevedo & Jair C. Soares. (2021) New agents and perspectives in the pharmacological treatment of major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 106, pages 110157.
Crossref
Cara Hoepner, Roger McIntyre & George Papakostas. (2021) Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence. Nutrients 13:3, pages 767.
Crossref
Supriya Mishra, Vikram Jeet Singh, Pooja A Chawla & Viney Chawla. (2021) Neuroprotective Role of Nutritional Supplementation in Athletes. Current Molecular Pharmacology 15:1, pages 129-142.
Crossref
Mahsa Sadat Zia, Elham Afkhami, Hamid Taher Neshat-Doost, Mahgol Tavakoli, Hossein Ali Mehrabi Kooshki & Laura Jobson. (2020) A brief clinical report documenting a novel therapeutic technique (MEmory Specificity Training, MEST) for depression: a summary of two pilot randomized controlled trials. Behavioural and Cognitive Psychotherapy 49:1, pages 118-123.
Crossref
Samia Joca, Gabriela P. Silote, Ariandra Sartim, Amanda Sales, Francisco Guimarães & Gregers Wegener. 2021. The Neuroscience of Depression. The Neuroscience of Depression 459 467 .
Bastian Schirmer & Roland Seifert. 2021. Arzneiverordnungs-Report 2021. Arzneiverordnungs-Report 2021 109 125 .
Alexei Verkhratsky, Vladimir Parpura, Caterina Scuderi & Baoman Li. 2021. Astrocytes in Psychiatric Disorders. Astrocytes in Psychiatric Disorders 317 347 .
Daniil Grinchii & Eliyahu Dremencov. (2020) Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders. International Journal of Molecular Sciences 21:24, pages 9532.
Crossref
E. Leahy, M. Varney & D. Brunner. 2020. Phenotypic Drug Discovery. Phenotypic Drug Discovery 175 197 .
Aila J. Ahola, Lina Radzeviciene, Linda Zaharenko, Tomislav Bulum, Sabīne Skrebinska, Edita Prakapiene, Kristina Blaslov, Vinko Roso, Vita Rovite, Valdis Pirags, Lea Duvnjak, Jelizaveta Sokolovska, Rasa Verkauskiene & Carol Forsblom. (2020) Association between symptoms of depression, diabetes complications and vascular risk factors in four European cohorts of individuals with type 1 diabetes – InterDiane Consortium. Diabetes Research and Clinical Practice 170, pages 108495.
Crossref
. (2020) AANP Forum. The Journal for Nurse Practitioners 16:9, pages A17-A20.
Crossref
Richard J. Zeifman, Anne C. Wagner, Ros Watts, Hannes Kettner, Lea J. Mertens & Robin L. Carhart-Harris. (2020) Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation. Frontiers in Psychiatry 11.
Crossref
Roland Seifert & Bastian Schirmer. (2020) A simple mechanistic terminology of psychoactive drugs: a proposal. Naunyn-Schmiedeberg's Archives of Pharmacology 393:8, pages 1331-1339.
Crossref
Gerasimos N. Konstantinou, Simone N. Vigod, Shobha Mehta, Zafiris J. Daskalakis & Daniel M. Blumberger. (2020) “A systematic review of non-invasive neurostimulation for the treatment of depression during pregnancy”. Journal of Affective Disorders 272, pages 259-268.
Crossref
Eva Češková & Martin Hýža. (2020) Treatment possibilities of pharmaco-resistant schizofrenie in common clinical practice. Psychiatrie pro praxi 21:2, pages 78-82.
Crossref
Rashita Makkar, Tapan Behl, Simona Bungau, Gokhan Zengin, Vineet Mehta, Arun Kumar, Md. Sahab Uddin, Ghulam Md. Ashraf, Mohamed M. Abdel-Daim, Sandeep Arora & Roxana Oancea. (2020) Nutraceuticals in Neurological Disorders. International Journal of Molecular Sciences 21:12, pages 4424.
Crossref
Ayman Guirguis, Joseph Chilcot, Michael Almond, Andrew Davenport, David Wellsted & Ken Farrington. (2020) Antidepressant Usage in Haemodialysis Patients: Evidence of Sub‐Optimal Practice Patterns. Journal of Renal Care 46:2, pages 124-132.
Crossref
Rakesh Jain, Jonathan Meyer, Angela Wehr, Bhaskar Rege, Lisa von Moltke & Peter J. Weiden. (2019) Size matters: the importance of particle size in a newly developed injectable formulation for the treatment of schizophrenia. CNS Spectrums 25:3, pages 323-330.
Crossref
Andrea Carlo Rossetti, Maria Serena Paladini, Marco Andrea Riva & Raffaella Molteni. (2020) Oxidation-reduction mechanisms in psychiatric disorders: A novel target for pharmacological intervention. Pharmacology & Therapeutics 210, pages 107520.
Crossref
Chen Zhu, Xinwei Li, Bangyi Zhao, Weiqing Peng, Wei Li & Wei Fu. (2020) Discovery of aryl-piperidine derivatives as potential antipsychotic agents using molecular hybridization strategy. European Journal of Medicinal Chemistry 193, pages 112214.
Crossref
Philip D. Harvey, Hiroshi Nakamura & Sadanori Miura. (2019) Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study. Neuropsychopharmacology Reports 40:1, pages 63-72.
Crossref
Anna K. Schmidtner, David A. Slattery, Joachim Gläsner, Andreas Hiergeist, Katharina Gryksa, Victoria A. Malik, Julian Hellmann-Regen, Isabella Heuser, Thomas C. Baghai, André Gessner, Rainer Rupprecht, Barbara Di Benedetto & Inga D. Neumann. (2019) Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner. Translational Psychiatry 9:1.
Crossref
Miloslav Kopeček. (2019) Brexpiprazole. Praktické lékárenství 15:E-verze 1/19.
Crossref
Samuel W. Centanni, Bridget D. Morris, Joseph R. Luchsinger, Gaurav Bedse, Tracy L. Fetterly, Sachin Patel & Danny G. Winder. (2018) Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence. Neuropsychopharmacology 44:3, pages 526-537.
Crossref
V. V. Gultyaeva, M. I. Zinchenko, D. Y. Uryumtsev, S. G. Krivoschekov & L. I. Aftanas. (2019) Exercise for depression treatment. Physiological mechanisms. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:7, pages 112.
Crossref
Deborah Galvão Coelho da Silva, Luiz Kae Sales Kanazawa & Débora Dalla Vecchia. (2019) Schizophrenia: effects of aripiprazole in metabolic syndrome. Brazilian Journal of Pharmaceutical Sciences 55.
Crossref
Christian C. Felder. 2019. Neuropsychotherapeutics. Neuropsychotherapeutics 1 20 .
Joseph P. Barsuglia, Martin Polanco, Robert Palmer, Benjamin J. Malcolm, Benjamin Kelmendi & Tanya Calvey. 2018. Psychedelic Neuroscience. Psychedelic Neuroscience 121 158 .